Guide to drug usage in adult patients with impaired renal function. A supplement.

Four previously published tables describing maintenance dosage intervals for common drugs used in patients with renal disease are supplemented and updated. Emphasis is given to the use of biological half-life and creatinine clearance for modification of the usual dose schedules. Toxic effects and adjustments required by patients undergoing dialysis are also noted.

[1]  K. Sloth,et al.  Acute renal insufficiency during treatment with azathioprine. , 2009, Acta medica Scandinavica.

[2]  T. Bergan,et al.  Renal excretion of gentamycin in chronic pyelonephritis. , 2009, Acta medica Scandinavica.

[3]  J. Puschett,et al.  Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies. , 1972, The Journal of clinical investigation.

[4]  P. Uldall,et al.  Sterility and cyclophosphamide. , 1972, Lancet.

[5]  K. Fairley,et al.  Sterility and testicular atrophy related to cyclophosphamide therapy. , 1972, Lancet.

[6]  A. Forrey,et al.  Correlation of serum creatinine concentration and gentamicin half-life. , 1972, JAMA.

[7]  S B Lucas,et al.  Computer-assisted prescribing of kanamycin for patients with renal insufficiency. , 1972, Lancet.

[8]  R. Bryant,et al.  Neomycin absorption in man. Studies of oral and enema administration and effect of intestinal ulceration. , 1972, Annals of internal medicine.

[9]  A. Leon,et al.  Absorption and metabolism of levodopa. , 1971, JAMA.

[10]  W. G. Walker,et al.  Carbenicillin-induced acidosis and seizures. , 1971, JAMA.

[11]  P. Hyams,et al.  The use of gentamicin in peritoneal dialysis. I. Pharmacologic results. , 1971, The Journal of infectious diseases.

[12]  J. Burke,et al.  Renal insufficiency associated with gentamicin therapy. , 1971, The Journal of infectious diseases.

[13]  N. Gary.  Peritoneal clearance and removal of gentamicin. , 1971, The Journal of infectious diseases.

[14]  G. Jackson,et al.  Pharmacology of gentamicin in man. , 1971, The Journal of infectious diseases.

[15]  A. Forrey,et al.  Pharmacokinetics of gentamicin: distribution and plasma and renal clearance. , 1971, The Journal of infectious diseases.

[16]  E. Vesell,et al.  Disposition of Morphine in Man , 1971, Science.

[17]  G. Schreiner.  Dialysis of Poisons and Drugs , 1971, Transactions - American Society for Artificial Internal Organs.

[18]  A. Glazko,et al.  Diphenylhydantoin metabolism in uremia. , 1971, The New England journal of medicine.

[19]  V. Sidel,et al.  Adverse reactions to sulfisoxazole, sulfamethoxazole, and nitrofurantoin. Manifestations and specific reaction rates during 2,118 courses of therapy. , 1971, Archives of internal medicine.

[20]  K. Melmon,et al.  The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man. , 1971, American heart journal.

[21]  J. Toole,et al.  Neural, hematologic and bacteriologic effects of nitrofurantoin in renal insufficiency. , 1971, The American journal of medicine.

[22]  E. Buescher,et al.  Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. , 1971, The Journal of infectious diseases.

[23]  C. Bahr,et al.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. , 1971, The New England journal of medicine.

[24]  C. Davison.  SALICYLATE METABOLISM IN MAN , 1971, Annals of the New York Academy of Sciences.

[25]  R. Wolen,et al.  Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration. , 1971, Toxicology and applied pharmacology.

[26]  J. Estes.  THE KINETICS OF HEPARIN * , 1971, Annals of the New York Academy of Sciences.

[27]  D. S. Lukas.  SOME ASPECTS OF THE DISTRIBUTION AND DISPOSITION OF DIGITOXIN IN MAN * , 1971, Annals of the New York Academy of Sciences.

[28]  G. Levy.  DRUG BIOTRANSFORMATION INTERACTIONS IN MAN: NONNARCOTIC ANALGESICS * , 1971, Annals of the New York Academy of Sciences.

[29]  B. Berkowitz.  INFLUENCE OF PLASMA LEVELS AND METABOLISM ON PHARMACOLOGICAL ACTIVITY: PENTAZOCINE * , 1971, Annals of the New York Academy of Sciences.

[30]  J. Koch-weser.  PHARMACOKINETICS OF PROCAINAMIDE IN MAN * , 1971 .

[31]  D. Kaye,et al.  Human pharmacology and clinical evaluation of an oral carbenicillin preparation , 1971, Clinical pharmacology and therapeutics.

[32]  F. O'grady.  Antibiotics in renal failure. , 1971, Lancet.

[33]  B. Reisberg,et al.  Cephalexin: Absorption and Excretion as Related to Renal Function and Hemodialysis , 1971, Infection and immunity.

[34]  J. Koch-weser,et al.  Procainamide dosage schedules, plasma concentrations, and clinical effects. , 1971, JAMA.

[35]  W. Warner,et al.  Neuromuscular blockade associated with gentamicin therapy. , 1971, JAMA.

[36]  W. Johnson,et al.  Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. , 1971, The New England journal of medicine.

[37]  Kirby Wm,et al.  Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients. , 1971 .

[38]  R. Patterson,et al.  Renal tubular acidosis due to amphotericin B nephrotoxicity. , 1971, Archives of internal medicine.

[39]  Black Hr,et al.  Blood, urine and tissue concentrations of the cephalosporin antibiotics in normal subjects. , 1971 .

[40]  J. Wagner,et al.  Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration. , 1971, Annals of internal medicine.

[41]  L. Humair,et al.  Pharmacokinetics of cephalexin in renal insufficiency. , 1971, Postgraduate medical journal.

[42]  D. Crozier,et al.  Carbenicillin-induced bleeding disorder. , 1970, Lancet.

[43]  C. Cox,et al.  Bacteriologic and pharmacodynamic aspects of nalidixic acid. , 1970, The Journal of urology.

[44]  W. Ritschel.  Biological Half-Lives of Drugs , 1970 .

[45]  W. Bennett,et al.  A practical guide to drug usage in adult patients with impaired renal function. , 1970, JAMA.

[46]  W. Mahon,et al.  Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function. , 1970, Canadian Medical Association journal.

[47]  Bailey Rr,et al.  The effect of impairment of renal function and haemodialysis on serum and urine levels of cephalexin. , 1970 .

[48]  I. Smith,et al.  Cephalexin in patients with renal disease. , 1970, The New England journal of medicine.

[49]  A. Proudfoot,et al.  Acute Paracetamol Poisoning , 1970, Nursing mirror and midwives journal.

[50]  Little Pj,et al.  Tetracyclines and renal failure. , 1970 .

[51]  T. Chalmers,et al.  Deafness complicating antibiotic therapy of hepatic encephalopathy. , 1970, Annals of internal medicine.

[52]  P. Band,et al.  Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. , 1970, The New England journal of medicine.

[53]  T. Hoffman,et al.  Carbenicillin therapy of Pseudomonas and other gram-negative bacillary infections. , 1970, Annals of internal medicine.

[54]  R. Riggio,et al.  Ototoxicity induced by furosemide. , 1970, The New England journal of medicine.

[55]  E. Federman,et al.  Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. , 1970, Annals of internal medicine.

[56]  M. Ogilvie,et al.  Carbenicillin-induced coagulopathy. , 1970, Lancet.

[57]  C. McMartin,et al.  The fate of guanethidine in two hypertensive patients , 1970, Clinical pharmacology and therapeutics.

[58]  G. L. Kantor.  Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy. , 1970, JAMA.

[59]  T. Tupasi,et al.  Mechanisms responsible for plasma levels of nafcillin lower than those of oxacillin. , 1970, Archives of internal medicine.

[60]  C. Kunin,et al.  Oral cephalexin and ampicillin: antimicrobial activity, recovery in urine, and persistence in blood of uremic patients. , 1970, Annals of internal medicine.

[61]  D. Teitelbaum,et al.  Isoniazid self‐poisoning , 1970, Neurology.

[62]  Roy Rb,et al.  Tricyclic antidepressant poisoning. , 1970 .

[63]  S. Kabins,et al.  Cephalexin therapy as related to renal function. , 1970, The American journal of the medical sciences.

[64]  S. Curatola,et al.  Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals. , 1970, The Journal of urology.

[65]  J. Oates,et al.  Plasma propranolol levels in adults With observations in four children , 1970, Clinical pharmacology and therapeutics.

[66]  R. Graw,et al.  Chlorpropamide intoxication--treatment with peritoneal dialysis. , 1970, Pediatrics.

[67]  E. Sellers,et al.  Protein binding and vascular activity of diazoxide. , 1969, The New England journal of medicine.

[68]  J. Bennett,et al.  A pharmacologic guide to the clinical use of amphotericin B. , 1969, The Journal of infectious diseases.

[69]  E. Way,et al.  Metabolism and excretion of pentazocine in man , 1969, Clinical pharmacology and therapeutics.

[70]  A. Amdisen,et al.  HEMODIALYSIS FOR LITHIUM POISONING , 1969 .

[71]  L. Prescott.  The metabolism of phenacetin in patients with renal disease , 1969, Clinical pharmacology and therapeutics.

[72]  C. Cox.  Gentamicin, a new aminoglycoside antibiotic: clinical and laboratory studies in urinary tract infection. , 1969, The Journal of infectious diseases.

[73]  H. D. Cohn.  Clinical studies with a new rifamycin derivative. , 1969, The Journal of clinical pharmacology and the journal of new drugs.

[74]  P. Tierno,et al.  Hemodialysis properties of clindamycin (7-chloro-7-deoxylincomycin). , 1969, Applied microbiology.

[75]  Holloway Wj.  Gentamicin--a new antibiotic. , 1969 .

[76]  George C. Cotzias,et al.  Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.

[77]  V. Devita,et al.  Pneumocystis carinii pneumonia: successful diagnosis treatment of two patients with associated malignant processes. , 1969, The New England journal of medicine.

[78]  R. Perkins,et al.  Drug Actions Interactions & Reactions , 1969, The American journal of the medical sciences.

[79]  W. Johnson,et al.  Cephaloglycin. Clinical and laboratory experience with an orally administered cephalosporin. , 1968, JAMA.

[80]  H. M. Solomon,et al.  Failure of probenecid to inhibit the rate of metabolism of tolbutamide in man , 1968, Clinical pharmacology and therapeutics.

[81]  A. C. Buck,et al.  Absorption of antibiotics during peritoneal dialysis in patients with renal failure , 1968, Journal of clinical pathology.

[82]  R. Mcmahon,et al.  CARBOHYDRATE METABOLISM IN UREMIA: BLOOD GLUCOSE RESPONSE TO SULFONYLUREA , 1967, The American journal of the medical sciences.

[83]  A. Lindberg,et al.  Concentration of chloramphenicol in the urine and blood in relation to renal function. , 1966, British medical journal.

[84]  J. D. de Silva,et al.  Blood level distribution patterns of diazepam and its major metabolite in man. , 1966, Journal of pharmaceutical sciences.

[85]  E. Henderson,et al.  The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. , 1965, Cancer research.

[86]  B. Koechlin,et al.  THE METABOLIC FATE OF C14-LABELED CHLORDIAZEPOXIDE IN MAN, IN THE DOG, AND IN THE RAT. , 1965, The Journal of pharmacology and experimental therapeutics.

[87]  P. Cannon,et al.  THE METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS. , 1964, The Journal of pharmacology and experimental therapeutics.

[88]  M. Maxwell,et al.  NEPHROTIC SYNDROME ASSOCIATED WITH PENICILLAMINE THERAPY OF WILSON'S DISEASE. , 1964, The American journal of medicine.

[89]  R A O'REILLY,et al.  STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN. , 1963, The Journal of clinical investigation.

[90]  V. Place,et al.  Clinical pharmacology of ethambutol. , 1963, The American review of respiratory disease.

[91]  A. Done.  Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion. , 1960, Pediatrics.

[92]  G. S. Gordon,et al.  Studies with chlorothiazide tagged with radioactive carbon (C14) in human beings. , 1960, Archives of internal medicine.

[93]  S. Sherlock,et al.  Systemic absorption of orally administered neomycin in liver disease. , 1960, The New England journal of medicine.

[94]  M. Goldman,et al.  Increasing the effectiveness of gold therapy in rheumatoid arthritis. , 1958, Journal of the American Medical Association.

[95]  G. Burch,et al.  The urinary excretion and biologic decay periods of radiomercury labeling a mercurial diuretic in normal and diseased man. , 1950, The Journal of clinical investigation.

[96]  C. Kunin.  Antibiotic Usage in Patients with Renal Impairment , 1972 .

[97]  M. Reidenberg.  Renal Function and Drug Action , 1971 .

[98]  J. Maher,et al.  Extracorporeal and Peritoneal Dialysis of Drugs , 1971 .

[99]  R. Venuto,et al.  Cephalothin handling in patients undergoing hemodialysis. , 1970, Antimicrobial agents and chemotherapy.

[100]  McCloskey Rv,et al.  Evaluation of the Cutler-Orme method for administration of kanamycin during renal failure. , 1970 .

[101]  D. Wombolt,et al.  Vasculitis with allopurinol therapy. , 1970, American heart journal.

[102]  R. Anderson,et al.  Uremia, deafness, and paralysis due to irrigating antibiotic solutions. , 1970, Archives of internal medicine.

[103]  J. K. Healy,et al.  Nephrotoxic effects of amphotericin B, including renal tubular acidosis. , 1969, The American journal of medicine.

[104]  H. Lebovitz,et al.  Carbohydrate metabolism in uremia. , 1968, Annals of internal medicine.

[105]  W. El.  II. Distribution and metabolism of morphine and its surrogates. , 1968 .

[106]  V. Devita,et al.  Pneumocystis carinii pneumonia. , 1968, Annals of internal medicine.

[107]  Hayes Cp,et al.  Plasma levels of dicloxacillin in oliguric patients and the effect of hemodialysis. , 1967 .

[108]  M. Brook,et al.  Effect of hemodialysis on dicloxacillin concentration in plasma. , 1967, Antimicrobial agents and chemotherapy.

[109]  E. Peets,et al.  THE ABSORPTION, EXCRETION, AND METABOLIC FATE OF ETHAMBUTOL IN MAN. , 1965, The American review of respiratory disease.